De Buhr et al. [46] identified two potential risk factors in elderly male patients—reduced DNase activity and increased LL-37 plasma levels—that may lead to an inefficient neutrophil extracellular trap (NET) degradation and a higher risk of NET-associated thrombosis during COVID-19. Here, CAMP is linked to COVID-19.